BRAND(AED)
Germany - WertheimBiotechnology
Focus: BRAND is a publicly traded German biotech company (501-1000 employees) specializing in liquid handling technologies and life sciences instrumentation. The company operates across infectious diseases, metabolic diseases, and diagnostic segments from its Wertheim headquarters.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
38
Should You Work at BRAND?
AI assessmentBRAND is a stable, growing mid-cap biotech ideal for operations, commercial, and technical roles, but risky for those seeking immersion in clinical development or R&D prestige.
Why Work Here
- Public company status (ticker AED) provides stability, equity upside potential, and established HR infrastructure (18 active HR roles)
- Expansion phase: 39 open positions across 11 departments signals growth investment, particularly in Sales (6 roles) and HR
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
38 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for BRAND
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.